Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
2. 3-ethyl 5-methyl (4s)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate Benzenesulfonate (1:1)
1. 150566-71-5
2. (s)-amlodipine Besylate
3. Levamlodipine Besilate
4. (-)-amlodipine Besylate
5. Levamlodipine Besilate [who-dd]
6. S-amlodipine Benzenesulfonate
7. Levoamlodipine Besylate
8. 885h5yc40l
9. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
10. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Monobenzenesulfonate
11. Benzenesulfonic Acid;3-o-ethyl 5-o-methyl (4s)-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
12. 3,5-pyridinedicarboxylic Acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
13. Unii-885h5yc40l
14. (s)-amlodipinebesylate
15. Hy-14744a
16. Cs-0090891
17. 129l824
18. Q27269892
19. (s)-amlodipine Besylate (103129-82-4(free Base))
20. 192583-58-7
Molecular Weight | 567.1 g/mol |
---|---|
Molecular Formula | C26H31ClN2O8S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 11 |
Exact Mass | 566.1489648 g/mol |
Monoisotopic Mass | 566.1489648 g/mol |
Topological Polar Surface Area | 163 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Levoamlodipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levoamlodipine, including repackagers and relabelers. The FDA regulates Levoamlodipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levoamlodipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levoamlodipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levoamlodipine supplier is an individual or a company that provides Levoamlodipine active pharmaceutical ingredient (API) or Levoamlodipine finished formulations upon request. The Levoamlodipine suppliers may include Levoamlodipine API manufacturers, exporters, distributors and traders.
click here to find a list of Levoamlodipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levoamlodipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Levoamlodipine active pharmaceutical ingredient (API) in detail. Different forms of Levoamlodipine DMFs exist exist since differing nations have different regulations, such as Levoamlodipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levoamlodipine DMF submitted to regulatory agencies in the US is known as a USDMF. Levoamlodipine USDMF includes data on Levoamlodipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levoamlodipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levoamlodipine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levoamlodipine Drug Master File in Korea (Levoamlodipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levoamlodipine. The MFDS reviews the Levoamlodipine KDMF as part of the drug registration process and uses the information provided in the Levoamlodipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levoamlodipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levoamlodipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levoamlodipine suppliers with KDMF on PharmaCompass.
A Levoamlodipine written confirmation (Levoamlodipine WC) is an official document issued by a regulatory agency to a Levoamlodipine manufacturer, verifying that the manufacturing facility of a Levoamlodipine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levoamlodipine APIs or Levoamlodipine finished pharmaceutical products to another nation, regulatory agencies frequently require a Levoamlodipine WC (written confirmation) as part of the regulatory process.
click here to find a list of Levoamlodipine suppliers with Written Confirmation (WC) on PharmaCompass.
Levoamlodipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levoamlodipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levoamlodipine GMP manufacturer or Levoamlodipine GMP API supplier for your needs.
A Levoamlodipine CoA (Certificate of Analysis) is a formal document that attests to Levoamlodipine's compliance with Levoamlodipine specifications and serves as a tool for batch-level quality control.
Levoamlodipine CoA mostly includes findings from lab analyses of a specific batch. For each Levoamlodipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levoamlodipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levoamlodipine EP), Levoamlodipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levoamlodipine USP).
LOOKING FOR A SUPPLIER?